Scott Dorfman

Scott Dorfman currently serves on the Board of Directors for Stord and DriverReach, and holds various leadership roles including Executive Chair and Chief Executive Officer at Odylia Therapeutics. In addition, Scott Dorfman is an Advisory Board Member at BioNeex and Nacuity Pharmaceuticals, Inc., and a Venture Partner and Advisory Board Member at Fulcrum Equity Partners. Scott Dorfman has been involved with Dropoff, Complemar, and USHER 2020 FOUNDATION INC as a member of their Board of Directors since December 2017, July 2017, and May 2015, respectively. Scott Dorfman received a BBA in General Business from the University of Georgia's Terry College of Business from 1975 to 1979.